These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 30100910)

  • 1. Human Plasmablast Migration Toward CXCL12 Requires Glucose Oxidation by Enhanced Pyruvate Dehydrogenase Activity
    Pak HK; Nam B; Lee YK; Kim YW; Roh J; Son J; Chung YS; Choe J; Park CS
    Front Immunol; 2018; 9():1742. PubMed ID: 30100910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulator of G protein signaling 1 suppresses CXCL12-mediated migration and AKT activation in RPMI 8226 human plasmacytoma cells and plasmablasts.
    Pak HK; Gil M; Lee Y; Lee H; Lee AN; Roh J; Park CS
    PLoS One; 2015; 10(4):e0124793. PubMed ID: 25897806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of orexin A on glucose metabolism in human hepatocellular carcinoma in vitro via PI3K/Akt/mTOR-dependent and -independent mechanism.
    Liu Y; Zhao Y; Guo L
    Mol Cell Endocrinol; 2016 Jan; 420():208-16. PubMed ID: 26549689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Akt plays an important role in breast cancer cell chemotaxis to CXCL12.
    Zhao M; Mueller BM; DiScipio RG; Schraufstatter IU
    Breast Cancer Res Treat; 2008 Jul; 110(2):211-22. PubMed ID: 17687643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD99 regulates CXCL12-induced chemotaxis of human plasma cells.
    Gil M; Pak HK; Lee AN; Park SJ; Lee Y; Roh J; Lee H; Chung YS; Park CS
    Immunol Lett; 2015 Dec; 168(2):329-36. PubMed ID: 26522646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL9 causes heterologous desensitization of CXCL12-mediated memory T lymphocyte activation.
    Giegold O; Ogrissek N; Richter C; Schröder M; Herrero San Juan M; Pfeilschifter JM; Radeke HH
    J Immunol; 2013 Apr; 190(7):3696-705. PubMed ID: 23447686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orexin A affects HepG2 human hepatocellular carcinoma cells glucose metabolism via HIF-1α-dependent and -independent mechanism.
    Wan X; Liu Y; Zhao Y; Sun X; Fan D; Guo L
    PLoS One; 2017; 12(9):e0184213. PubMed ID: 28886081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12.
    Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML
    Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slit-2/Robo-1 modulates the CXCL12/CXCR4-induced chemotaxis of T cells.
    Prasad A; Qamri Z; Wu J; Ganju RK
    J Leukoc Biol; 2007 Sep; 82(3):465-76. PubMed ID: 17565045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTOR regulates vascular smooth muscle cell differentiation from human bone marrow-derived mesenchymal progenitors.
    Hegner B; Lange M; Kusch A; Essin K; Sezer O; Schulze-Lohoff E; Luft FC; Gollasch M; Dragun D
    Arterioscler Thromb Vasc Biol; 2009 Feb; 29(2):232-8. PubMed ID: 19074484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell death of prostate cancer cells by specific amino acid restriction depends on alterations of glucose metabolism.
    Fu YM; Lin H; Liu X; Fang W; Meadows GG
    J Cell Physiol; 2010 Aug; 224(2):491-500. PubMed ID: 20432447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia inhibits the SDF-1-dependent migration of human leukemic cell line HL-60 via blocking of Akt activation.
    Seo YJ; Koh SH; Kang HJ; Shin HY; Jeong G; Ahn HS
    Biochem Biophys Res Commun; 2007 Dec; 364(2):388-94. PubMed ID: 17950696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of pyruvate dehydrogenase activation by increased cardiac work.
    Kobayashi K; Neely JR
    J Mol Cell Cardiol; 1983 Jun; 15(6):369-82. PubMed ID: 6876186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
    Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
    Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migration of human umbilical cord blood mesenchymal stem cells mediated by stromal cell-derived factor-1/CXCR4 axis via Akt, ERK, and p38 signal transduction pathways.
    Ryu CH; Park SA; Kim SM; Lim JY; Jeong CH; Jun JA; Oh JH; Park SH; Oh WI; Jeun SS
    Biochem Biophys Res Commun; 2010 Jul; 398(1):105-10. PubMed ID: 20558135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of AMP-activated protein kinase, inhibition of pyruvate dehydrogenase activity, and redistribution of substrate partitioning mediate the acute insulin-sensitizing effects of troglitazone in skeletal muscle cells.
    Fediuc S; Pimenta AS; Gaidhu MP; Ceddia RB
    J Cell Physiol; 2008 May; 215(2):392-400. PubMed ID: 17960559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stromal Cell-Derived Factor-1α Promotes Endothelial Colony-Forming Cell Migration Through the Ca
    Zuccolo E; Di Buduo C; Lodola F; Orecchioni S; Scarpellino G; Kheder DA; Poletto V; Guerra G; Bertolini F; Balduini A; Rosti V; Moccia F
    Stem Cells Dev; 2018 Jan; 27(1):23-34. PubMed ID: 29121817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired hippocampal glucose metabolism during and after flurothyl-induced seizures in mice: Reduced phosphorylation coincides with reduced activity of pyruvate dehydrogenase.
    McDonald TS; Borges K
    Epilepsia; 2017 Jul; 58(7):1172-1180. PubMed ID: 28632902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pyruvate dehydrogenase activity and citric acid cycle intermediates during high cardiac power generation.
    Sharma N; Okere IC; Brunengraber DZ; McElfresh TA; King KL; Sterk JP; Huang H; Chandler MP; Stanley WC
    J Physiol; 2005 Jan; 562(Pt 2):593-603. PubMed ID: 15550462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and function of CXCL12/CXCR4/CXCR7 in thyroid cancer.
    Zhu X; Bai Q; Lu Y; Lu Y; Zhu L; Zhou X; Wu L
    Int J Oncol; 2016 Jun; 48(6):2321-9. PubMed ID: 27082011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.